Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda
The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regular...
The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regular...